LivaNova PLC LIVN

Latest FY: 2025 Healthcare Medical Devices
Market Price $82.25
Market Cap $4.51B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑10.7% YoY
$1.39B
3-Yr CAGR: 10.8%
Net Income ↓-483.5% YoY
-$242.47M
Net Margin: -17.5%
Free Cash Flow ↑27.5% YoY
$173.29M
FCF Yield: 3.84%
EPS (Diluted) ↓-483.6% YoY
$-4.45
Basic: $-4.45
Return on Equity Efficiency
-20.2%
ROA: -659.4%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (LIVN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $1,213.9M $704.4M $-62.8M $-1.29 $90.2M $53.7M
FY 2017 $1,012.3M -16.6% $651.6M $-25.1M +60.0% $-0.52 +59.7% $91.3M $57.2M +6.6%
FY 2018 $1,107.0M +9.4% $745.1M $-189.4M -654.9% $-3.91 -651.9% $120.5M $82.5M +44.1%
FY 2019 $1,084.2M -2.1% $337.7M $-155.2M +18.1% $-3.21 +17.9% $-91.1M $-115.8M -240.4%
FY 2020 $934.2M -13.8% $594.8M $-345.0M -122.3% $-7.10 -121.2% $-79.4M $-114.4M +1.2%
FY 2021 $1,035.4M +10.8% $706.0M $-135.8M +60.6% $-2.68 +62.3% $102.5M $77.1M +167.3%
FY 2022 $1,021.8M -1.3% $707.2M $-86.2M +36.5% $-1.61 +39.9% $69.9M $43.4M -43.7%
FY 2023 $1,153.5M +12.9% $771.2M $17.5M +120.3% $0.32 +119.9% $74.9M $39.9M -8.0%
FY 2024 $1,253.4M +8.7% $870.9M $63.2M +260.4% $1.16 +262.5% $183.0M $135.9M +240.4%
FY 2025 $1,388.1M +10.7% $939.9M $-242.5M -483.5% $-4.45 -483.6% $254.3M $173.3M +27.5%
$

Valuation

Market Price $82.25
Market Cap $4.51B
Enterprise Value $4.25B
P/E Ratio N/A
P/B Ratio 3.77
FCF Yield 3.84%
Dividend Yield N/A
Shares Outstanding 54,933,500
%

Profitability & Margins

Gross Margin 67.71%
Operating Margin 14.36%
Net Margin -17.47%
Return on Equity (ROE) -20.21%
Return on Assets (ROA) -659.44%
Asset Turnover 37.75x
Revenue 3-Yr CAGR 10.75%
🛡️

Financial Health & Liquidity

Current Ratio 0.39
Cash Ratio 6.72
Debt / Equity 0.313
Debt / Assets 10.228
Cash & Equivalents $635.55M
Total Debt $376.06M
Book Value / Share $21.84
💧

Cash Flow Efficiency

Operating Cash Flow $254.34M
Capital Expenditures (CapEx) $81.05M
Free Cash Flow $173.29M
OCF / Revenue 18.32%
FCF / Revenue 12.48%
FCF 3-Yr CAGR 58.64%
🏷️

Per Share Metrics

EPS (Diluted) $-4.45
EPS (Basic) $-4.45
Dividends / Share N/A
Book Value / Share $21.84
EPS YoY Growth -483.62%
🏛️

Balance Sheet (FY 2025)

Total Assets $36.77M
Total Liabilities $94.57M
Stockholders' Equity $1.20B
Current Assets $36.77M
Current Liabilities $94.57M